Published in AIDS Weekly, November 9th, 2009
"Antigen-specific interferon gamma (IFN gamma) responses to the RD-1 antigens ESAT-6 and CFP-10 (T-SPOT. TB and QuantiFERON-TB-Gold-In-Tube), heparin-binding haemagglutinin and purified protein derivative were evaluated, using alveolar lavage cells, in 91 consecutively recruited South African patients suspected of having TB. Of 85 evaluable patients (29% HIV+), 24, 11, 48 and 2 had definite...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.